The Effects of Pacifier-Activated Lullaby on Oral Feeding Among Preterm Infants
Nemours Children's Clinic · NCT07819734
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 8 mo–8 mo · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 46
- US sites recruiting
- 1
- Study start
- November 16, 2020
- Record last updated
- September 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Preterm infants often have difficulty learning how to feed by mouth because the coordination of sucking, swallowing, and breathing develops later in pregnancy. Delays in achieving full oral feeding can prolong hospitalization and increase the need for tube feeding.
This study evaluated whether a Pacifier-Activated Lullaby (PAL) system could improve oral feeding performance in preterm infants. The PAL device plays a recorded maternal or caregiver voice when an infant generates an adequate non-nutritive suck on a pacifier, providing positive reinforcement during feeding development.
In this randomized controlled trial conducted at Nemours Children's Hospital in Orlando, Florida, preterm infants who were transitioning from tube feeding to oral feeding were assigned either to receive PAL therapy in addition to standard feeding care or to receive standard feeding care alone. Researchers compared measures of oral feeding performance, feeding efficiency, growth, and progression toward independent oral feeding between the two groups.
The goal of the study was to determine whether reinforcing non-nutritive sucking with auditory feedback could enhance feeding development and improve clinical outcomes in preterm infants. The information gained from this study may help clinicians better understand the role of music-assisted feeding interventions in neonatal care and identify which infants are most likely to benefit from this approach.
Being studied: Pacifier-Activated Lullaby (PAL) Therapy
Conditions: Dysphagia of Newborn
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Preterm infants born at less than 32 weeks gestational age
- Postmenstrual age between 34 0/7 and 35 6/7 weeks at enrollment
- Receiving at least half of nutritional intake enterally and less than half orally
- Written informed consent obtained from parent(s) or legal guardian(s)
Exclusion Criteria
- Mechanical ventilation at enrollment
- Continuous positive airway pressure (CPAP) support
- High-flow nasal cannula support >2 L/min
- Determined by the treating medical team to be unsafe for oral feeding
- Determined by feeding or speech specialists to be unsafe for oral feeding
- Clinical instability preventing participation in study procedures
Recruiting US locations
Nemours Children's Hospital, Florida
Orlando, FL 32827
Site contact: Caroline Chua, MD · 407-307-6786 · caroline.chua@nemours.org
Study contacts (from the official record)
- Caroline Chua, MD · 407-307-6786 · caroline.chua@nemours.org
- Sreekanth Viswanathan, MD · 4076977603 · sreekanth.viswanathan@nemours.org
Similar studies in Florida
All pregnancy studies in Florida →- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- North Miami Beach, FL + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Margate, FL + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay…
American Laboratory Products Company
- Location
- North Miami, FL + 5 other US sites
- Eligibility basics
- Ages 13+
- RecruitingPhase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Aerogen Pharma Limited
- Location
- Jacksonville, FL + 17 other US sites
- Eligibility basics
- Any age listed